Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID-19: A population-based study

被引：10
|
作者：
Zhou, Jiandong [1 ]
Tse, Gary
Lee, Sharen [2 ]
Liu, Tong [3 ]
Cao, Zhidong [4 ]
Zeng, Daniel Dajun [4 ]
Leung, Keith Sai Kit [5 ]
Wai, Abraham Ka Chung [5 ]
Wong, Ian Chi Kei [6 ,7 ]
Cheung, Bernard Man Yung [8 ]
Zhang, Qingpeng [1 ]
机构：
[1] City Univ Hong Kong, Sch Data Sci, Hong Kong, Peoples R China
[2] Tianjin Med Univ, Second Hosp, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Dept Cardiol,Tianjin Inst Cardiol, Tianjin, Peoples R China
[3] Li Ka Shing Inst Hlth Sci, Lab Cardiovasc Physiol, Cardiovasc Analyt Grp, Hong Kong, Peoples R China
[4] Chinese Acad Sci, Inst Automat, Beijing, Beijing, Peoples R China
[5] Univ Hong Kong, Emergency Med Unit, Hong Kong, Peoples R China
[6] Univ Hong Kong, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China
[7] UCL, Med Optimisat Res & Educ CMORE, Sch Pharm, London, England
[8] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 05期
关键词：
D O I：
10.1002/jmv.26904
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：2635 / 2641
页数：7
相关论文
共 50 条
  • [1] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [2] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Li, Xiao-Long
    Li, Tao
    Du, Qi-Cong
    Yang, Li
    He, Kun-Lun
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5462 - 5469
  • [3] COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    St John, Megan H.
    Barry, Arden R.
    CANADIAN PHARMACISTS JOURNAL, 2020, 153 (04) : 193 - 197
  • [4] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and clinical outcomes of COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (04) : 1603 - 1604
  • [5] COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence?
    Patel, Ankit B.
    Verma, Ashish
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1769 - 1770
  • [6] Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
    Khalili, Azadeh
    Karim, Hosein
    Bayat, Gholamreza
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (04) : 312 - 316
  • [7] Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study
    Hu, Wei-Syun
    Lin, Cheng-Li
    MEDICINE, 2023, 102 (22) : E33875
  • [8] The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
    Harky, Amer
    Chor, Cheryl Yan Ting
    Nixon, Henry
    Jeilani, Milad
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2021, 22 (01)
  • [9] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
  • [10] Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease
    Tse, Gary
    Zhou, Jiandong
    Lee, Sharen
    Wong, Wing Tak
    Li, Xintao
    Liu, Tong
    Cao, Zhidong
    Zeng, Daniel Dajun
    Wai, Abraham K. C.
    Wong, Ian Chi Kei
    Cheung, Bernard Man Yung
    Zhang, Qingpeng
    JOURNAL OF HYPERTENSION, 2021, 39 (08) : 1717 - 1724
12345